COVID-19 Impact on Global Patent Medicine Market Insights, Forecast to 2026
Patent Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Patent Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Patent Medicine market is segmented into
The Patent Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Patent Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Patent Medicine Market Share Analysis
Patent Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Patent Medicine business, the date to enter into the Patent Medicine market, Patent Medicine product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Patent Medicine market is segmented into
- Product Patents
- Process Patents
- Adult
- Children
The Patent Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Patent Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Patent Medicine Market Share Analysis
Patent Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Patent Medicine business, the date to enter into the Patent Medicine market, Patent Medicine product introduction, recent developments, etc.
The major vendors covered:
- Pfizer Inc.
- Otsuka Pharmaceutical
- Merck
- Novartis
- Sanofi-Aventis
- Bristol-Myers Squibb Co.
- GSK
1 STUDY COVERAGE
1.1 Patent Medicine Product Introduction
1.2 Market Segments
1.3 Key Patent Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Patent Medicine Market Size Growth Rate by Type
1.4.2 Product Patents
1.4.3 Process Patents
1.5 Market by Application
1.5.1 Global Patent Medicine Market Size Growth Rate by Application
1.5.2 Adult
1.5.3 Children
1.6 Coronavirus Disease 2019 (Covid-19): Patent Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Patent Medicine Industry
1.6.1.1 Patent Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Patent Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Patent Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Patent Medicine Market Size Estimates and Forecasts
2.1.1 Global Patent Medicine Revenue 2015-2026
2.1.2 Global Patent Medicine Sales 2015-2026
2.2 Patent Medicine Market Size by Region: 2020 Versus 2026
2.2.1 Global Patent Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Patent Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PATENT MEDICINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Patent Medicine Sales by Manufacturers
3.1.1 Patent Medicine Sales by Manufacturers (2015-2020)
3.1.2 Patent Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Patent Medicine Revenue by Manufacturers
3.2.1 Patent Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Patent Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Patent Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Patent Medicine Revenue in 2019
3.2.5 Global Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Patent Medicine Price by Manufacturers
3.4 Patent Medicine Manufacturing Base Distribution, Product Types
3.4.1 Patent Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Patent Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Patent Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Patent Medicine Market Size by Type (2015-2020)
4.1.1 Global Patent Medicine Sales by Type (2015-2020)
4.1.2 Global Patent Medicine Revenue by Type (2015-2020)
4.1.3 Patent Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Patent Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Patent Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Patent Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Patent Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Patent Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Patent Medicine Market Size by Application (2015-2020)
5.1.1 Global Patent Medicine Sales by Application (2015-2020)
5.1.2 Global Patent Medicine Revenue by Application (2015-2020)
5.1.3 Patent Medicine Price by Application (2015-2020)
5.2 Patent Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Patent Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Patent Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Patent Medicine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Patent Medicine by Country
6.1.1 North America Patent Medicine Sales by Country
6.1.2 North America Patent Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Patent Medicine Market Facts & Figures by Type
6.3 North America Patent Medicine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Patent Medicine by Country
7.1.1 Europe Patent Medicine Sales by Country
7.1.2 Europe Patent Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Patent Medicine Market Facts & Figures by Type
7.3 Europe Patent Medicine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Patent Medicine by Region
8.1.1 Asia Pacific Patent Medicine Sales by Region
8.1.2 Asia Pacific Patent Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Patent Medicine Market Facts & Figures by Type
8.3 Asia Pacific Patent Medicine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Patent Medicine by Country
9.1.1 Latin America Patent Medicine Sales by Country
9.1.2 Latin America Patent Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Patent Medicine Market Facts & Figures by Type
9.3 Central & South America Patent Medicine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Patent Medicine by Country
10.1.1 Middle East and Africa Patent Medicine Sales by Country
10.1.2 Middle East and Africa Patent Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Patent Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Patent Medicine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description, Business Overview and Total Revenue
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Patent Medicine Products Offered
11.1.5 Pfizer Inc. Recent Development
11.2 Otsuka Pharmaceutical
11.2.1 Otsuka Pharmaceutical Corporation Information
11.2.2 Otsuka Pharmaceutical Description, Business Overview and Total Revenue
11.2.3 Otsuka Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Otsuka Pharmaceutical Patent Medicine Products Offered
11.2.5 Otsuka Pharmaceutical Recent Development
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description, Business Overview and Total Revenue
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Patent Medicine Products Offered
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description, Business Overview and Total Revenue
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Patent Medicine Products Offered
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Corporation Information
11.5.2 Sanofi-Aventis Description, Business Overview and Total Revenue
11.5.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi-Aventis Patent Medicine Products Offered
11.5.5 Sanofi-Aventis Recent Development
11.6 Bristol-Myers Squibb Co.
11.6.1 Bristol-Myers Squibb Co. Corporation Information
11.6.2 Bristol-Myers Squibb Co. Description, Business Overview and Total Revenue
11.6.3 Bristol-Myers Squibb Co. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Co. Patent Medicine Products Offered
11.6.5 Bristol-Myers Squibb Co. Recent Development
11.7 GSK
11.7.1 GSK Corporation Information
11.7.2 GSK Description, Business Overview and Total Revenue
11.7.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GSK Patent Medicine Products Offered
11.7.5 GSK Recent Development
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description, Business Overview and Total Revenue
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Patent Medicine Products Offered
11.1.5 Pfizer Inc. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Patent Medicine Market Estimates and Projections by Region
12.1.1 Global Patent Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Patent Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Patent Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Patent Medicine Sales Forecast (2021-2026)
12.2.2 North America: Patent Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Patent Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Patent Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Patent Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Patent Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Patent Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Patent Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Patent Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Patent Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Patent Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Patent Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Patent Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Patent Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Patent Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Patent Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Patent Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Patent Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Patent Medicine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Patent Medicine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Patent Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Patent Medicine Product Introduction
1.2 Market Segments
1.3 Key Patent Medicine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Patent Medicine Market Size Growth Rate by Type
1.4.2 Product Patents
1.4.3 Process Patents
1.5 Market by Application
1.5.1 Global Patent Medicine Market Size Growth Rate by Application
1.5.2 Adult
1.5.3 Children
1.6 Coronavirus Disease 2019 (Covid-19): Patent Medicine Industry Impact
1.6.1 How the Covid-19 is Affecting the Patent Medicine Industry
1.6.1.1 Patent Medicine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Patent Medicine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Patent Medicine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Patent Medicine Market Size Estimates and Forecasts
2.1.1 Global Patent Medicine Revenue 2015-2026
2.1.2 Global Patent Medicine Sales 2015-2026
2.2 Patent Medicine Market Size by Region: 2020 Versus 2026
2.2.1 Global Patent Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Patent Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PATENT MEDICINE COMPETITOR LANDSCAPE BY PLAYERS
3.1 Patent Medicine Sales by Manufacturers
3.1.1 Patent Medicine Sales by Manufacturers (2015-2020)
3.1.2 Patent Medicine Sales Market Share by Manufacturers (2015-2020)
3.2 Patent Medicine Revenue by Manufacturers
3.2.1 Patent Medicine Revenue by Manufacturers (2015-2020)
3.2.2 Patent Medicine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Patent Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Patent Medicine Revenue in 2019
3.2.5 Global Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Patent Medicine Price by Manufacturers
3.4 Patent Medicine Manufacturing Base Distribution, Product Types
3.4.1 Patent Medicine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Patent Medicine Product Type
3.4.3 Date of International Manufacturers Enter into Patent Medicine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Patent Medicine Market Size by Type (2015-2020)
4.1.1 Global Patent Medicine Sales by Type (2015-2020)
4.1.2 Global Patent Medicine Revenue by Type (2015-2020)
4.1.3 Patent Medicine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Patent Medicine Market Size Forecast by Type (2021-2026)
4.2.1 Global Patent Medicine Sales Forecast by Type (2021-2026)
4.2.2 Global Patent Medicine Revenue Forecast by Type (2021-2026)
4.2.3 Patent Medicine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Patent Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Patent Medicine Market Size by Application (2015-2020)
5.1.1 Global Patent Medicine Sales by Application (2015-2020)
5.1.2 Global Patent Medicine Revenue by Application (2015-2020)
5.1.3 Patent Medicine Price by Application (2015-2020)
5.2 Patent Medicine Market Size Forecast by Application (2021-2026)
5.2.1 Global Patent Medicine Sales Forecast by Application (2021-2026)
5.2.2 Global Patent Medicine Revenue Forecast by Application (2021-2026)
5.2.3 Global Patent Medicine Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Patent Medicine by Country
6.1.1 North America Patent Medicine Sales by Country
6.1.2 North America Patent Medicine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Patent Medicine Market Facts & Figures by Type
6.3 North America Patent Medicine Market Facts & Figures by Application
7 EUROPE
7.1 Europe Patent Medicine by Country
7.1.1 Europe Patent Medicine Sales by Country
7.1.2 Europe Patent Medicine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Patent Medicine Market Facts & Figures by Type
7.3 Europe Patent Medicine Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Patent Medicine by Region
8.1.1 Asia Pacific Patent Medicine Sales by Region
8.1.2 Asia Pacific Patent Medicine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Patent Medicine Market Facts & Figures by Type
8.3 Asia Pacific Patent Medicine Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Patent Medicine by Country
9.1.1 Latin America Patent Medicine Sales by Country
9.1.2 Latin America Patent Medicine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Patent Medicine Market Facts & Figures by Type
9.3 Central & South America Patent Medicine Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Patent Medicine by Country
10.1.1 Middle East and Africa Patent Medicine Sales by Country
10.1.2 Middle East and Africa Patent Medicine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Patent Medicine Market Facts & Figures by Type
10.3 Middle East and Africa Patent Medicine Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description, Business Overview and Total Revenue
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Patent Medicine Products Offered
11.1.5 Pfizer Inc. Recent Development
11.2 Otsuka Pharmaceutical
11.2.1 Otsuka Pharmaceutical Corporation Information
11.2.2 Otsuka Pharmaceutical Description, Business Overview and Total Revenue
11.2.3 Otsuka Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Otsuka Pharmaceutical Patent Medicine Products Offered
11.2.5 Otsuka Pharmaceutical Recent Development
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description, Business Overview and Total Revenue
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Patent Medicine Products Offered
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description, Business Overview and Total Revenue
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Patent Medicine Products Offered
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Corporation Information
11.5.2 Sanofi-Aventis Description, Business Overview and Total Revenue
11.5.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sanofi-Aventis Patent Medicine Products Offered
11.5.5 Sanofi-Aventis Recent Development
11.6 Bristol-Myers Squibb Co.
11.6.1 Bristol-Myers Squibb Co. Corporation Information
11.6.2 Bristol-Myers Squibb Co. Description, Business Overview and Total Revenue
11.6.3 Bristol-Myers Squibb Co. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Co. Patent Medicine Products Offered
11.6.5 Bristol-Myers Squibb Co. Recent Development
11.7 GSK
11.7.1 GSK Corporation Information
11.7.2 GSK Description, Business Overview and Total Revenue
11.7.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GSK Patent Medicine Products Offered
11.7.5 GSK Recent Development
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Description, Business Overview and Total Revenue
11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Inc. Patent Medicine Products Offered
11.1.5 Pfizer Inc. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Patent Medicine Market Estimates and Projections by Region
12.1.1 Global Patent Medicine Sales Forecast by Regions 2021-2026
12.1.2 Global Patent Medicine Revenue Forecast by Regions 2021-2026
12.2 North America Patent Medicine Market Size Forecast (2021-2026)
12.2.1 North America: Patent Medicine Sales Forecast (2021-2026)
12.2.2 North America: Patent Medicine Revenue Forecast (2021-2026)
12.2.3 North America: Patent Medicine Market Size Forecast by Country (2021-2026)
12.3 Europe Patent Medicine Market Size Forecast (2021-2026)
12.3.1 Europe: Patent Medicine Sales Forecast (2021-2026)
12.3.2 Europe: Patent Medicine Revenue Forecast (2021-2026)
12.3.3 Europe: Patent Medicine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Patent Medicine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Patent Medicine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Patent Medicine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Patent Medicine Market Size Forecast by Region (2021-2026)
12.5 Latin America Patent Medicine Market Size Forecast (2021-2026)
12.5.1 Latin America: Patent Medicine Sales Forecast (2021-2026)
12.5.2 Latin America: Patent Medicine Revenue Forecast (2021-2026)
12.5.3 Latin America: Patent Medicine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Patent Medicine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Patent Medicine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Patent Medicine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Patent Medicine Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Patent Medicine Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Patent Medicine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Patent Medicine Market Segments
Table 2. Ranking of Global Top Patent Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Patent Medicine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Product Patents
Table 5. Major Manufacturers of Process Patents
Table 6. COVID-19 Impact Global Market: (Four Patent Medicine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Patent Medicine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Patent Medicine Players to Combat Covid-19 Impact
Table 11. Global Patent Medicine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 12. Global Patent Medicine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Patent Medicine Sales by Regions 2015-2020 (K Doses)
Table 14. Global Patent Medicine Sales Market Share by Regions (2015-2020)
Table 15. Global Patent Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Patent Medicine Sales by Manufacturers (2015-2020) (K Doses)
Table 17. Global Patent Medicine Sales Share by Manufacturers (2015-2020)
Table 18. Global Patent Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patent Medicine as of 2019)
Table 20. Patent Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Patent Medicine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Patent Medicine Price (2015-2020) (USD/Dose)
Table 23. Patent Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Patent Medicine Product Type
Table 25. Date of International Manufacturers Enter into Patent Medicine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 28. Global Patent Medicine Sales Share by Type (2015-2020)
Table 29. Global Patent Medicine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Patent Medicine Revenue Share by Type (2015-2020)
Table 31. Patent Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 32. Global Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 33. Global Patent Medicine Sales Share by Application (2015-2020)
Table 34. North America Patent Medicine Sales by Country (2015-2020) (K Doses)
Table 35. North America Patent Medicine Sales Market Share by Country (2015-2020)
Table 36. North America Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Patent Medicine Revenue Market Share by Country (2015-2020)
Table 38. North America Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 39. North America Patent Medicine Sales Market Share by Type (2015-2020)
Table 40. North America Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 41. North America Patent Medicine Sales Market Share by Application (2015-2020)
Table 42. Europe Patent Medicine Sales by Country (2015-2020) (K Doses)
Table 43. Europe Patent Medicine Sales Market Share by Country (2015-2020)
Table 44. Europe Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Patent Medicine Revenue Market Share by Country (2015-2020)
Table 46. Europe Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 47. Europe Patent Medicine Sales Market Share by Type (2015-2020)
Table 48. Europe Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 49. Europe Patent Medicine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Patent Medicine Sales by Region (2015-2020) (K Doses)
Table 51. Asia Pacific Patent Medicine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Patent Medicine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Patent Medicine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 55. Asia Pacific Patent Medicine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 57. Asia Pacific Patent Medicine Sales Market Share by Application (2015-2020)
Table 58. Latin America Patent Medicine Sales by Country (2015-2020) (K Doses)
Table 59. Latin America Patent Medicine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Patent Medicine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 63. Latin America Patent Medicine Sales Market Share by Type (2015-2020)
Table 64. Latin America Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 65. Latin America Patent Medicine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Patent Medicine Sales by Country (2015-2020) (K Doses)
Table 67. Middle East and Africa Patent Medicine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Patent Medicine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 71. Middle East and Africa Patent Medicine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 73. Middle East and Africa Patent Medicine Sales Market Share by Application (2015-2020)
Table 74. Pfizer Inc. Corporation Information
Table 75. Pfizer Inc. Description and Major Businesses
Table 76. Pfizer Inc. Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Pfizer Inc. Product
Table 78. Pfizer Inc. Recent Development
Table 79. Otsuka Pharmaceutical Corporation Information
Table 80. Otsuka Pharmaceutical Description and Major Businesses
Table 81. Otsuka Pharmaceutical Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Otsuka Pharmaceutical Product
Table 83. Otsuka Pharmaceutical Recent Development
Table 84. Merck Corporation Information
Table 85. Merck Description and Major Businesses
Table 86. Merck Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Merck Product
Table 88. Merck Recent Development
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Major Businesses
Table 91. Novartis Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Novartis Product
Table 93. Novartis Recent Development
Table 94. Sanofi-Aventis Corporation Information
Table 95. Sanofi-Aventis Description and Major Businesses
Table 96. Sanofi-Aventis Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Sanofi-Aventis Product
Table 98. Sanofi-Aventis Recent Development
Table 99. Bristol-Myers Squibb Co. Corporation Information
Table 100. Bristol-Myers Squibb Co. Description and Major Businesses
Table 101. Bristol-Myers Squibb Co. Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Bristol-Myers Squibb Co. Product
Table 103. Bristol-Myers Squibb Co. Recent Development
Table 104. GSK Corporation Information
Table 105. GSK Description and Major Businesses
Table 106. GSK Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. GSK Product
Table 108. GSK Recent Development
Table 109. Global Patent Medicine Sales Forecast by Regions (2021-2026) (K Doses)
Table 110. Global Patent Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Patent Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Patent Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Patent Medicine Sales Forecast by Country (2021-2026) (K Doses)
Table 114. North America: Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Patent Medicine Sales Forecast by Country (2021-2026) (K Doses)
Table 116. Europe: Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Patent Medicine Sales Forecast by Region (2021-2026) (K Doses)
Table 118. Asia Pacific: Patent Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Patent Medicine Sales Forecast by Country (2021-2026) (K Doses)
Table 120. Latin America: Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Patent Medicine Sales Forecast by Country (2021-2026) (K Doses)
Table 122. Middle East and Africa: Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Patent Medicine Players
Table 127. Patent Medicine Customers List
Table 128. Patent Medicine Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 1. Patent Medicine Market Segments
Table 2. Ranking of Global Top Patent Medicine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Patent Medicine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Product Patents
Table 5. Major Manufacturers of Process Patents
Table 6. COVID-19 Impact Global Market: (Four Patent Medicine Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Patent Medicine Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Patent Medicine Players to Combat Covid-19 Impact
Table 11. Global Patent Medicine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 12. Global Patent Medicine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 13. Global Patent Medicine Sales by Regions 2015-2020 (K Doses)
Table 14. Global Patent Medicine Sales Market Share by Regions (2015-2020)
Table 15. Global Patent Medicine Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Patent Medicine Sales by Manufacturers (2015-2020) (K Doses)
Table 17. Global Patent Medicine Sales Share by Manufacturers (2015-2020)
Table 18. Global Patent Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Patent Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Patent Medicine as of 2019)
Table 20. Patent Medicine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Patent Medicine Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Patent Medicine Price (2015-2020) (USD/Dose)
Table 23. Patent Medicine Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Patent Medicine Product Type
Table 25. Date of International Manufacturers Enter into Patent Medicine Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 28. Global Patent Medicine Sales Share by Type (2015-2020)
Table 29. Global Patent Medicine Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Patent Medicine Revenue Share by Type (2015-2020)
Table 31. Patent Medicine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 32. Global Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 33. Global Patent Medicine Sales Share by Application (2015-2020)
Table 34. North America Patent Medicine Sales by Country (2015-2020) (K Doses)
Table 35. North America Patent Medicine Sales Market Share by Country (2015-2020)
Table 36. North America Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Patent Medicine Revenue Market Share by Country (2015-2020)
Table 38. North America Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 39. North America Patent Medicine Sales Market Share by Type (2015-2020)
Table 40. North America Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 41. North America Patent Medicine Sales Market Share by Application (2015-2020)
Table 42. Europe Patent Medicine Sales by Country (2015-2020) (K Doses)
Table 43. Europe Patent Medicine Sales Market Share by Country (2015-2020)
Table 44. Europe Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Patent Medicine Revenue Market Share by Country (2015-2020)
Table 46. Europe Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 47. Europe Patent Medicine Sales Market Share by Type (2015-2020)
Table 48. Europe Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 49. Europe Patent Medicine Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Patent Medicine Sales by Region (2015-2020) (K Doses)
Table 51. Asia Pacific Patent Medicine Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Patent Medicine Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Patent Medicine Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 55. Asia Pacific Patent Medicine Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 57. Asia Pacific Patent Medicine Sales Market Share by Application (2015-2020)
Table 58. Latin America Patent Medicine Sales by Country (2015-2020) (K Doses)
Table 59. Latin America Patent Medicine Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Patent Medicine Revenue Market Share by Country (2015-2020)
Table 62. Latin America Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 63. Latin America Patent Medicine Sales Market Share by Type (2015-2020)
Table 64. Latin America Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 65. Latin America Patent Medicine Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Patent Medicine Sales by Country (2015-2020) (K Doses)
Table 67. Middle East and Africa Patent Medicine Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Patent Medicine Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Patent Medicine Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Patent Medicine Sales by Type (2015-2020) (K Doses)
Table 71. Middle East and Africa Patent Medicine Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Patent Medicine Sales by Application (2015-2020) (K Doses)
Table 73. Middle East and Africa Patent Medicine Sales Market Share by Application (2015-2020)
Table 74. Pfizer Inc. Corporation Information
Table 75. Pfizer Inc. Description and Major Businesses
Table 76. Pfizer Inc. Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. Pfizer Inc. Product
Table 78. Pfizer Inc. Recent Development
Table 79. Otsuka Pharmaceutical Corporation Information
Table 80. Otsuka Pharmaceutical Description and Major Businesses
Table 81. Otsuka Pharmaceutical Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Otsuka Pharmaceutical Product
Table 83. Otsuka Pharmaceutical Recent Development
Table 84. Merck Corporation Information
Table 85. Merck Description and Major Businesses
Table 86. Merck Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Merck Product
Table 88. Merck Recent Development
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Major Businesses
Table 91. Novartis Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. Novartis Product
Table 93. Novartis Recent Development
Table 94. Sanofi-Aventis Corporation Information
Table 95. Sanofi-Aventis Description and Major Businesses
Table 96. Sanofi-Aventis Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Sanofi-Aventis Product
Table 98. Sanofi-Aventis Recent Development
Table 99. Bristol-Myers Squibb Co. Corporation Information
Table 100. Bristol-Myers Squibb Co. Description and Major Businesses
Table 101. Bristol-Myers Squibb Co. Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Bristol-Myers Squibb Co. Product
Table 103. Bristol-Myers Squibb Co. Recent Development
Table 104. GSK Corporation Information
Table 105. GSK Description and Major Businesses
Table 106. GSK Patent Medicine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. GSK Product
Table 108. GSK Recent Development
Table 109. Global Patent Medicine Sales Forecast by Regions (2021-2026) (K Doses)
Table 110. Global Patent Medicine Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Patent Medicine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Patent Medicine Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Patent Medicine Sales Forecast by Country (2021-2026) (K Doses)
Table 114. North America: Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Patent Medicine Sales Forecast by Country (2021-2026) (K Doses)
Table 116. Europe: Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Patent Medicine Sales Forecast by Region (2021-2026) (K Doses)
Table 118. Asia Pacific: Patent Medicine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Patent Medicine Sales Forecast by Country (2021-2026) (K Doses)
Table 120. Latin America: Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Patent Medicine Sales Forecast by Country (2021-2026) (K Doses)
Table 122. Middle East and Africa: Patent Medicine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Patent Medicine Players
Table 127. Patent Medicine Customers List
Table 128. Patent Medicine Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Patent Medicine Product Picture
Figure 2. Global Patent Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Product Patents Product Picture
Figure 4. Process Patents Product Picture
Figure 5. Global Patent Medicine Sales Market Share by Application in 2020 & 2026
Figure 6. Adult
Figure 7. Children
Figure 8. Patent Medicine Report Years Considered
Figure 9. Global Patent Medicine Market Size 2015-2026 (US$ Million)
Figure 10. Global Patent Medicine Sales 2015-2026 (K Doses)
Figure 11. Global Patent Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Patent Medicine Sales Market Share by Region (2015-2020)
Figure 13. Global Patent Medicine Sales Market Share by Region in 2019
Figure 14. Global Patent Medicine Revenue Market Share by Region (2015-2020)
Figure 15. Global Patent Medicine Revenue Market Share by Region in 2019
Figure 16. Global Patent Medicine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Patent Medicine Revenue in 2019
Figure 18. Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Patent Medicine Sales Market Share by Type (2015-2020)
Figure 20. Global Patent Medicine Sales Market Share by Type in 2019
Figure 21. Global Patent Medicine Revenue Market Share by Type (2015-2020)
Figure 22. Global Patent Medicine Revenue Market Share by Type in 2019
Figure 23. Global Patent Medicine Market Share by Price Range (2015-2020)
Figure 24. Global Patent Medicine Sales Market Share by Application (2015-2020)
Figure 25. Global Patent Medicine Sales Market Share by Application in 2019
Figure 26. Global Patent Medicine Revenue Market Share by Application (2015-2020)
Figure 27. Global Patent Medicine Revenue Market Share by Application in 2019
Figure 28. North America Patent Medicine Sales Growth Rate 2015-2020 (K Doses)
Figure 29. North America Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Patent Medicine Sales Market Share by Country in 2019
Figure 31. North America Patent Medicine Revenue Market Share by Country in 2019
Figure 32. U.S. Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.S. Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Canada Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Patent Medicine Market Share by Type in 2019
Figure 37. North America Patent Medicine Market Share by Application in 2019
Figure 38. Europe Patent Medicine Sales Growth Rate 2015-2020 (K Doses)
Figure 39. Europe Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Patent Medicine Sales Market Share by Country in 2019
Figure 41. Europe Patent Medicine Revenue Market Share by Country in 2019
Figure 42. Germany Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Germany Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. France Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.K. Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Italy Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Russia Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Patent Medicine Market Share by Type in 2019
Figure 53. Europe Patent Medicine Market Share by Application in 2019
Figure 54. Asia Pacific Patent Medicine Sales Growth Rate 2015-2020 (K Doses)
Figure 55. Asia Pacific Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Patent Medicine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Patent Medicine Revenue Market Share by Region in 2019
Figure 58. China Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 59. China Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Japan Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 63. South Korea Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 65. India Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Australia Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Taiwan Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Indonesia Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Thailand Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Malaysia Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Philippines Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Vietnam Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Patent Medicine Market Share by Type in 2019
Figure 81. Asia Pacific Patent Medicine Market Share by Application in 2019
Figure 82. Latin America Patent Medicine Sales Growth Rate 2015-2020 (K Doses)
Figure 83. Latin America Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Patent Medicine Sales Market Share by Country in 2019
Figure 85. Latin America Patent Medicine Revenue Market Share by Country in 2019
Figure 86. Mexico Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 87. Mexico Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Brazil Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Argentina Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Patent Medicine Market Share by Type in 2019
Figure 93. Latin America Patent Medicine Market Share by Application in 2019
Figure 94. Middle East and Africa Patent Medicine Sales Growth Rate 2015-2020 (K Doses)
Figure 95. Middle East and Africa Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Patent Medicine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Patent Medicine Revenue Market Share by Country in 2019
Figure 98. Turkey Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Turkey Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Saudi Arabia Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 103. U.A.E Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Patent Medicine Market Share by Type in 2019
Figure 105. Middle East and Africa Patent Medicine Market Share by Application in 2019
Figure 106. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Otsuka Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bristol-Myers Squibb Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Patent Medicine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 114. North America Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Patent Medicine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 116. Europe Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Patent Medicine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 118. Asia Pacific Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Patent Medicine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 120. Latin America Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Patent Medicine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 122. Middle East and Africa Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
Figure 1. Patent Medicine Product Picture
Figure 2. Global Patent Medicine Sales Market Share by Type in 2020 & 2026
Figure 3. Product Patents Product Picture
Figure 4. Process Patents Product Picture
Figure 5. Global Patent Medicine Sales Market Share by Application in 2020 & 2026
Figure 6. Adult
Figure 7. Children
Figure 8. Patent Medicine Report Years Considered
Figure 9. Global Patent Medicine Market Size 2015-2026 (US$ Million)
Figure 10. Global Patent Medicine Sales 2015-2026 (K Doses)
Figure 11. Global Patent Medicine Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Patent Medicine Sales Market Share by Region (2015-2020)
Figure 13. Global Patent Medicine Sales Market Share by Region in 2019
Figure 14. Global Patent Medicine Revenue Market Share by Region (2015-2020)
Figure 15. Global Patent Medicine Revenue Market Share by Region in 2019
Figure 16. Global Patent Medicine Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Patent Medicine Revenue in 2019
Figure 18. Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Patent Medicine Sales Market Share by Type (2015-2020)
Figure 20. Global Patent Medicine Sales Market Share by Type in 2019
Figure 21. Global Patent Medicine Revenue Market Share by Type (2015-2020)
Figure 22. Global Patent Medicine Revenue Market Share by Type in 2019
Figure 23. Global Patent Medicine Market Share by Price Range (2015-2020)
Figure 24. Global Patent Medicine Sales Market Share by Application (2015-2020)
Figure 25. Global Patent Medicine Sales Market Share by Application in 2019
Figure 26. Global Patent Medicine Revenue Market Share by Application (2015-2020)
Figure 27. Global Patent Medicine Revenue Market Share by Application in 2019
Figure 28. North America Patent Medicine Sales Growth Rate 2015-2020 (K Doses)
Figure 29. North America Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Patent Medicine Sales Market Share by Country in 2019
Figure 31. North America Patent Medicine Revenue Market Share by Country in 2019
Figure 32. U.S. Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.S. Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Canada Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Patent Medicine Market Share by Type in 2019
Figure 37. North America Patent Medicine Market Share by Application in 2019
Figure 38. Europe Patent Medicine Sales Growth Rate 2015-2020 (K Doses)
Figure 39. Europe Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Patent Medicine Sales Market Share by Country in 2019
Figure 41. Europe Patent Medicine Revenue Market Share by Country in 2019
Figure 42. Germany Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Germany Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 45. France Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.K. Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Italy Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Russia Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Patent Medicine Market Share by Type in 2019
Figure 53. Europe Patent Medicine Market Share by Application in 2019
Figure 54. Asia Pacific Patent Medicine Sales Growth Rate 2015-2020 (K Doses)
Figure 55. Asia Pacific Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Patent Medicine Sales Market Share by Region in 2019
Figure 57. Asia Pacific Patent Medicine Revenue Market Share by Region in 2019
Figure 58. China Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 59. China Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Japan Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 63. South Korea Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 65. India Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Australia Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Taiwan Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Indonesia Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Thailand Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Malaysia Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Philippines Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Vietnam Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Patent Medicine Market Share by Type in 2019
Figure 81. Asia Pacific Patent Medicine Market Share by Application in 2019
Figure 82. Latin America Patent Medicine Sales Growth Rate 2015-2020 (K Doses)
Figure 83. Latin America Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Patent Medicine Sales Market Share by Country in 2019
Figure 85. Latin America Patent Medicine Revenue Market Share by Country in 2019
Figure 86. Mexico Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 87. Mexico Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Brazil Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Argentina Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Patent Medicine Market Share by Type in 2019
Figure 93. Latin America Patent Medicine Market Share by Application in 2019
Figure 94. Middle East and Africa Patent Medicine Sales Growth Rate 2015-2020 (K Doses)
Figure 95. Middle East and Africa Patent Medicine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Patent Medicine Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Patent Medicine Revenue Market Share by Country in 2019
Figure 98. Turkey Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Turkey Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Saudi Arabia Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Patent Medicine Sales Growth Rate (2015-2020) (K Doses)
Figure 103. U.A.E Patent Medicine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Patent Medicine Market Share by Type in 2019
Figure 105. Middle East and Africa Patent Medicine Market Share by Application in 2019
Figure 106. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 107. Otsuka Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 108. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Bristol-Myers Squibb Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. North America Patent Medicine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 114. North America Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Patent Medicine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 116. Europe Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Patent Medicine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 118. Asia Pacific Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Patent Medicine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 120. Latin America Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Patent Medicine Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 122. Middle East and Africa Patent Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
